Allogene raises another $120m to develop ‘off-the-shelf’ CAR-Ts
Startup biotech already raised $300m earlier this year
Startup biotech already raised $300m earlier this year
Belldegrun and Chang’s Allogene to take over from Pfizer in R&D deal
US hospitals struggle to provide approved autologous therapies
Regulator agrees to restart phase 1 trial of UCART 123
Companies hope to challenge traiblazers Novartis and Kite.